Collegium Pharmaceutical, Inc Earning Date (COLL)

USA |NASDAQ |USD

COLL Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Aug 3, 2022 Jun 2022 - - $0.81
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Aug 3, 2022 Jun 2022 - - $82.94M

Collegium Pharmaceutical, Inc's next earnings date is Wednesday, Aug 3, 2022 for the fiscal quarter ending Jun 2022.

COLL Earnings Date & History Chart

COLL Earnings & Revenue Forecast

COLL Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2022 6 $4.35 $4.00 $4.96

COLL Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2022 0 / 1 $4.38 $4.38 $2.24

COLL Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2022 6 $375.68M $363.07M $398.01M

COLL Earnings Date & Revenue History

COLL Earnings History

|
Show More
Show More

COLL Revenue History

|
Show More
Show More

Collegium Pharmaceutical, Inc Next Earnings Date & Report

COLL Next Earnings Date & Report Preview: Jun 2022 (FQ)

COLL's next earnings date is Wednesday, Aug 3, 2022 for the fiscal quarter ending Jun 30, 2022.

Collegium Pharmaceutical, Inc Previous Earnings Dates & Reports

COLL Previous Earnings Date & Report Recap: Mar 2022 (FQ)

Collegium Pharmaceutical, Inc's previous earnings date was May 4, 2022 for its fiscal quarter ended Mar 31, 2022.

COLL Previous Earnings Date & Report Recap: Dec 2021 (FY)

Collegium Pharmaceutical, Inc's previous annual earnings date was Feb 24, 2022 for its fiscal year ended Dec 31, 2021.

COLL's earnings per share (EPS) was $2.04, missing the consensus analysts forecast of $3.68 by -44.61% , and lower than the previous year's EPS (Dec 2020) by -46.26%.

Revenues were $276.87M, worse than the forecast of $340.42M by -18.67%, and down by -10.69% from previous year's revenue.

The company reported a net income of $71.52M, 167.33% higher than the previous year.

Collegium Pharmaceutical, Inc reported a free cash flow of $0.10 for its fiscal year, compared to $-279.83M a year ago.

The company ended the fiscal year with $258.75M in total debt, an increase of 0.36% compared to the previous year.